Clinical RoundupFree A third of patients with lymph node-positive penile cancer don’t receive recommended care March 02, 2018Vol.44 No.09
FreeTrials & Tribulations A phase III trial seeks to determine whether diet and exercise can cure breast cancer March 02, 2018Vol.44 No.09By Jennifer A. Ligibel
FreeIn Brief Frederick Lab and Georgetown launch research, education collaboration March 02, 2018Vol.44 No.09
FreeIn Brief Fung and the Fox Chase BMT Program receives “Game Changer Award” March 02, 2018Vol.44 No.09
FreeIn Brief MD Anderson and RaySearch form alliance to advance radiation therapy March 02, 2018Vol.44 No.09
Conversation with The Cancer LetterFree PH.AI CEO Hyde: With Big Data, pharma will focus on the measurement of value March 02, 2018Vol.44 No.09By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Roche CEO O’Day: Our investment in Flatiron will accelerate their mission March 02, 2018Vol.44 No.09By Matthew Bin Han Ong
Free Roche to acquire Flatiron Health for $2.1 billion,with focus on real-world data March 02, 2018Vol.44 No.09By Matthew Bin Han Ong
